These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32393261)

  • 41. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
    Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
    BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stereotactic body radiation therapy for abdominal and pelvic oligometastases: Dosimetric targets for safe and effective local control.
    Rwigema JM; King C; Wang PC; Kamrava M; Kupelian P; Steinberg ML; Lee P
    Pract Radiat Oncol; 2015; 5(3):e183-e191. PubMed ID: 25413386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyberknife
    Telentschak S; Ruess D; Grau S; Goldbrunner R; von Spreckelsen N; Jablonska K; Treuer H; Kocher M; Ruge M
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2765-2773. PubMed ID: 33638006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stereotactic body radiotherapy for pulmonary oligometastases: a monoinstitutional analysis of clinical outcomes and potential prognostic factors.
    Cuccia F; Mazzola R; Figlia V; Giaj-Levra N; Nicosia L; Ricchetti F; Rigo M; Attinà G; Vitale C; Pastorello E; Ruggieri R; Alongi F
    Strahlenther Onkol; 2022 Oct; 198(10):934-939. PubMed ID: 35499694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution's comprehensive experience.
    Thibault I; Poon I; Yeung L; Erler D; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):713-9. PubMed ID: 25085765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CyberKnife stereotactic radiosurgery and stereotactic ablative radiation therapy of patients with prostate cancer bone metastases.
    Napieralska A; Miszczyk L; Stapor-Fudzinska M
    Neoplasma; 2016; 63(2):304-12. PubMed ID: 26774153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancer.
    Inoue T; Katoh N; Onimaru R; Shimizu S; Tsuchiya K; Suzuki R; Sakakibara-Konishi J; Shinagawa N; Oizumi S; Shirato H
    Radiat Oncol; 2013 Mar; 8():69. PubMed ID: 23518013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stereotactic ablative radiotherapy delivered by image-guided helical tomotherapy for extracranial oligometastases.
    Sole CV; Lopez Guerra JL; Matute R; Jaen J; Puebla F; Rivin E; Sanchez-Reyes A; Beltran C; Bourgier C; Calvo FA; Marsiglia H
    Clin Transl Oncol; 2013 Jun; 15(6):484-91. PubMed ID: 23143953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
    Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
    BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stereotactic Body Radiotherapy of Lymph Node Oligometastases.
    Burkoň P; Oberreiterová S; Kazda T; Slávik M; Bobek L; Komínek L; Procházka T; Vrzal M; Šlampa P
    Klin Onkol; 2020; 33(2):114-122. PubMed ID: 32303132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
    Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
    Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stereotactic Body Radiotherapy for Lymph-Nodal Oligometastatic Prostate Cancer: A Multicenter Retrospective Experience.
    Cuccia F; Tamburo M; Piras A; Mortellaro G; Iudica A; Daidone A; Federico M; Zagardo V; Ferini G; Marletta F; Spatola C; Fazio I; Filosto S; Pergolizzi S; Ferrera G
    Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629732
    [No Abstract]   [Full Text] [Related]  

  • 53. Phase II trial of high dose stereotactic body radiation therapy for lymph node oligometastases.
    Franzese C; Comito T; Tripoli A; Franceschini D; Clerici E; Navarria P; Badalamenti M; D'agostino G; Loi M; Mancosu P; Reggiori G; Tomatis S; Scorsetti M
    Clin Exp Metastasis; 2020 Oct; 37(5):565-573. PubMed ID: 32556682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors.
    Clerici E; Comito T; Franzese C; Di Brina L; Tozzi A; Iftode C; Navarria P; Mancosu P; Reggiori G; Tomatis S; Scorsetti M
    Strahlenther Onkol; 2020 Apr; 196(4):325-333. PubMed ID: 31605163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors.
    Nguyen KNB; Hause DJ; Novak J; Monjazeb AM; Daly ME
    Pract Radiat Oncol; 2019 Mar; 9(2):e196-e202. PubMed ID: 30496842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis.
    Stera S; Balermpas P; Chan MKH; Huttenlocher S; Wurster S; Keller C; Imhoff D; Rades D; Dunst J; Rödel C; Hildebrandt G; Blanck O
    Strahlenther Onkol; 2018 Feb; 194(2):143-155. PubMed ID: 28875297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potentially curative stereotactic body radiation therapy (SBRT) for single or oligometastasis to the lung.
    Oh D; Ahn YC; Seo JM; Shin EH; Park HC; Lim DH; Pyo H
    Acta Oncol; 2012 May; 51(5):596-602. PubMed ID: 22548366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer.
    Zhao X; Zhu X; Fei J; Ren H; Cao Y; Ju X; Yuan Z; Zhang H
    Radiat Oncol; 2018 Oct; 13(1):205. PubMed ID: 30348187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
    Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A multi-institutional analysis of fractionated versus single-fraction stereotactic body radiotherapy (SBRT) in the treatment of primary lung tumors: a comparison between two antipodal fractionations.
    Alongi F; Nicosia L; Figlia V; De Sanctis V; Mazzola R; Giaj-Levra N; Reverberi C; Valeriani M; Osti MF
    Clin Transl Oncol; 2021 Oct; 23(10):2133-2140. PubMed ID: 33840047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.